confirmed that WTAP was expressed at a significantly high level in gliomas and was closely correlated with the prognosis of patients with glioblastoma.97 Interestingly, WTAP was also described as a novel oncogenic protein in AML.98 However, the m6A‐associated mechanisms of WTAP in regulating the above cancers have not been elucidated. The gene discussed is WTAP; the disease is central nervous system cancer.